Literature DB >> 31135726

Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths.

Marcela C Smid1, Nicole M Stone, Laurie Baksh, Michelle P Debbink, Brett D Einerson, Michael W Varner, Adam J Gordon, Erin A S Clark.   

Abstract

OBJECTIVE: Drug-induced deaths, defined as intentional or unintentional consumption of illicit substances or diverted medications leading to death, are the leading cause of death for reproductive-age women in the United States. Our objective was to describe pregnancy-associated deaths attributed to drug-induced causes to identify opportunities for intervention.
METHODS: Using the Utah Perinatal Morality Review Committee database, we performed a retrospective cohort study of all pregnancy-associated deaths-death of a woman during pregnancy or within 1 year from the end of pregnancy-from 2005 to 2014. We performed a detailed descriptive analysis of women with drug-induced deaths. We compared characteristics of women with drug-induced and other pregnancy-associated deaths.
RESULTS: From 2005 to 2014, 136 pregnancy-associated deaths were identified. Drug-induced death was the leading cause of pregnancy-associated death (n=35, 26%) and 89% occurred in the postpartum period. More specifically, those with a drug-induced death were more likely to die in the late postpartum period, defined as death occurring within 43 days to 1 year of the end of the pregnancy, (n=28/35, 80%) compared with women whose deaths were from other pregnancy-associated causes (n=34/101, 34%) (P<.001). The majority of drug-induced deaths were attributed to opioids (n=27/35, 77%), prescription opioids (n=21/35, 60%), and polysubstance use (n=29/35, 83%). From 2005 to 2014, the pregnancy-associated mortality ratio increased 76%, from 23.3 in 2005 to 41.0 in 2014. During this same time period, the drug-induced pregnancy-associated mortality ratio increased 200%, from 3.9 in 2005 to 11.7 in 2014.
CONCLUSION: Drug-induced death is the leading cause of pregnancy-associated death in Utah and occurs primarily in the late postpartum period. Interventional studies focused on identifying and treating women at risk of drug-induced death are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31135726      PMCID: PMC6548332          DOI: 10.1097/AOG.0000000000003279

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

1.  Pregnancy-related substance use in the United States during 1996-1998.

Authors:  Shahul H Ebrahim; Joseph Gfroerer
Journal:  Obstet Gynecol       Date:  2003-02       Impact factor: 7.661

2.  Major Survey Findings of Listening to Mothers(SM) III: Pregnancy and Birth: Report of the Third National U.S. Survey of Women's Childbearing Experiences.

Authors:  Eugene R Declercq; Carol Sakala; Maureen P Corry; Sandra Applebaum; Ariel Herrlich
Journal:  J Perinat Educ       Date:  2014

3.  Association of clinical characteristics and cessation of tobacco, alcohol, and illicit drug use during pregnancy.

Authors:  Suena H Massey; Daniel Z Lieberman; David Reiss; Leslie D Leve; Daniel S Shaw; Jenae M Neiderhiser
Journal:  Am J Addict       Date:  2010-12-28

4.  Mood disorders affect drug treatment success of drug-dependent pregnant women.

Authors:  Heather E Fitzsimons; Michelle Tuten; Varsha Vaidya; Hendrée E Jones
Journal:  J Subst Abuse Treat       Date:  2006-10-13

5.  Opioid Knowledge and Prescribing Practices Among Obstetrician-Gynecologists.

Authors:  Annetta M Madsen; Lauren M Stark; Phinnara Has; Jenna B Emerson; Jay Schulkin; Kristen A Matteson
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

6.  ACOG Committee Opinion No. 736: Optimizing Postpartum Care.

Authors: 
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

7.  Methamphetamines and pregnancy outcomes.

Authors:  Tricia E Wright; Renee Schuetter; Jacqueline Tellei; Lynnae Sauvage
Journal:  J Addict Med       Date:  2015 Mar-Apr       Impact factor: 3.702

8.  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

9.  Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder.

Authors:  Sarah M Bagley; Howard Cabral; Kelley Saia; Alyssa Brown; Christine Lloyd-Travaglini; Alexander Y Walley; Ruth Rose-Jacobs
Journal:  Addict Sci Clin Pract       Date:  2018-12-14

10.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

View more
  24 in total

1.  Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction.

Authors:  Marcela C Smid; Charles W Schauberger; Mishka Terplan; Tricia E Wright
Journal:  Am J Obstet Gynecol MFM       Date:  2020-07-15

2.  Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.

Authors:  Timothy Nielsen; Dana Bernson; Mishka Terplan; Sarah E Wakeman; Amy M Yule; Pooja K Mehta; Monica Bharel; Hafsatou Diop; Elsie M Taveras; Timothy E Wilens; Davida M Schiff
Journal:  Addiction       Date:  2019-11-13       Impact factor: 6.526

3.  A pilot multisite study of patient navigation for pregnant women with opioid use disorder.

Authors:  Gerald Cochran; Marcela C Smid; Elizabeth E Krans; M Aryana Bryan; Adam J Gordon; Brad Lundahl; John Silipigni; Benjamin Haaland; Ralph Tarter
Journal:  Contemp Clin Trials       Date:  2019-11-12       Impact factor: 2.226

4.  Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.

Authors:  Erin Morris; Tyler Bardsley; Krista Schulte; Jeanette Seidel; Julie H Shakib; Karen F Buchi; Camille M Fung
Journal:  Am J Perinatol       Date:  2020-09-06       Impact factor: 1.862

5.  Addiction and Depression: Unmet Treatment Needs Among Reproductive Age Women.

Authors:  Caitlin E Martin; Anna Scialli; Mishka Terplan
Journal:  Matern Child Health J       Date:  2020-05

6.  Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum.

Authors:  Caitlin E Martin; Caroline Shadowen; Bhushan Thakkar; Travis Oakes; Tamas S Gal; F Gerard Moeller
Journal:  Curr Treat Options Psychiatry       Date:  2020-07-28

7.  Margerison et al. Respond to "Medicaid Policy and Reproductive Autonomy".

Authors:  Claire E Margerison; Robert Kaestner; Jiajia Chen; Colleen MacCallum-Bridges
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

8.  Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States.

Authors:  Marian Jarlenski; Elizabeth E Krans
Journal:  J Addict Med       Date:  2021 Nov-Dec 01       Impact factor: 3.702

9.  Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.

Authors:  Carolyn Sufrin; Lauren Sutherland; Lauren Beal; Mishka Terplan; Carl Latkin; Jennifer G Clarke
Journal:  Addiction       Date:  2020-03-18       Impact factor: 6.526

10.  Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study.

Authors:  Caitlin E Martin; Tawany Almeida; Bhushan Thakkar; Tiffany Kimbrough
Journal:  Subst Abus       Date:  2021-07-02       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.